Table 1.
Patient Demographics and Disease Characteristics
| Characteristic | (N = 16) |
|---|---|
| Age, y | 49.5 (29–64) |
| Sex, n (%) | |
| Female | 13 (81) |
| Male | 3 (19) |
| Height, cm | 164.5 (147–175) |
| Weight, kg | 66.2 (52–93) |
| BMI, kg/m2 | 24.7 (20–30) |
| Race, n (%) | |
| White/Caucasian/European | 14 (88) |
| Black/African | 1 (6) |
| Asian—Central/South Asian | 1 (6) |
| Primary tumor type, n (%) | |
| Colon/rectum cancer | 3 (19) |
| Thyroid cancer | 3 (19) |
| Melanoma | 2 (13) |
| NSCLC | 2 (13) |
| Breast cancer | 1 (6) |
| HCL | 1 (6) |
| LCH | 1 (6) |
| Liver cancer | 1 (6) |
| Lung adenocarcinoma | 1 (6) |
| SCLC | 1 (6) |
| Stage at screening, n (%) | |
| I | 2 (13) |
| IV | 13 (81) |
| Missing | 1 (6) |
| Prior anticancer therapy, n (%) | |
| Any therapy | 11 (69) |
| Chemotherapy | 10 (63) |
| Biologic therapy | 4 (25) |
| Hormonal therapy | 2 (13) |
| Immunotherapy | 2 (13) |
| Small‐molecule targeted therapy | 1 (6) |
| Time since diagnosis, days | 467.5 (21–7226) |
BMI, body mass index; HCL, hairy cell leukemia; LCH, Langerhans cell histiocytosis; NSCLC, non–small cell lung cancer; SCLC, small cell lung cancer.
Continuous data are presented as median (range).